GMiS Celebrates Women's Accomplishments Through Open Nominations

Nominate women in science, engineering and technology for the 2013 HENAAC Awards

2013-03-27

MONTEREY PARK, CA, March 27, 2013 (Press-News.org) In celebration of Women's History Month, Great Minds in STEMTM (GMiS) especially seeks nominations of technically-talented female engineers and scientists for its 25th Anniversary HENAAC Awards. These prestigious, peer-reviewed awards are presented to outstanding Science, Technology, Engineering, or Math (STEM) professionals who demonstrate high-caliber technical talent and a strong commitment to the Hispanic community.

The complete class of 2013 HENAAC honorees will be presented during the 25th Anniversary HENAAC Conference, to be held in New Orleans, LA, from October 3-5, 2013. Among the 25th Anniversary Host Sponsors are Lockheed Martin Corporation and The Boeing Company.

To date, GMiS has recognized over 170 outstanding professional females. This includes six women to its highly selective and elite HENAAC Hall of Fame:
- Dr. Ellen Ochoa (Director, NASA Johnson Space Center and former astronaut)
- Linda Garcia Cubero (Among the first class of women to graduate from the U.S. Air Force Academy, and the first Latina to graduate from any service academy)
- Susan Pacheco (Director, Global Advanced Product Marketing, Ford Motor Company)
- Dr. Nitza Margarita Cintron (Associate Professor of Internal Medicine, UTMB-Galveston)
- Dr. Lydia Villa-Komaroff (Chief Scientific Officer at CytonomeST and world-renowned molecular biologist)
- Dr. Cristina Amon (Dean, Faculty of Applied Science and Engineering at the University of Toronto and member of the National Academy of Engineering)

"I receive[d] an award that is very special to me, as a Hispanic woman and as a scientist," states Monserrate Roman, NASA Marshall Space Flight Center Chief Microbiologist and the 2012 HENAAC Award recipient for Outstanding Technical Achievement - Government. "Since I was in elementary school, I remember being in love with science. I remember how much I enjoyed the science classes and I remember teachers that foster[ed] my interest in science."

Nominations are evaluated based on a rigorous peer-review process that GMiS has refined over the years.

The nomination deadline is May 20, 2013. More information, including the guidelines, is available at www.greatmindsinstem.org or by contacting Kathy Borunda Barrera, Manager, Recognition Programs, at (323) 262-0997, ext. 300 or via email to kbbarrera@greatmindsinstem.org.

About Great Minds in STEMTM
Great Minds in STEMTM is an education, national 501c3 nonprofit, whose vision is to be a national leader in keeping America technologically strong by promoting science, technology, engineering and math careers especially in underserved communities. Now, in its 24th year, it remains the only national entity, which has consistently recognized the esteemed technical achievements of Hispanic role models through a selective, peer-reviewed process that honors the top-technical talent in a Hall of Fame. Please visit www.greatmindsinstem.org.

ELSE PRESS RELEASES FROM THIS DATE:

Booking All Inclusive is the Stress Free Way to Save on Holiday

2013-03-27

Leading UK tour operator Mercury Direct announce today that more and more holiday makers each year are choosing to go all inclusive while on holiday. With the UK economy stagnating, holiday makers have to work harder and harder to pay for luxury items such as a trip abroad, however savvy travellers have found that by going all inclusive money spent while they are away is significantly reduced. When planning a holiday most travellers often overlook how much that extras such as meals, drinks and snacks which are not included within their booked board basis, can add on ...

You don't 'own' your own genes

2013-03-26

NEW YORK (March 25, 2013) -- Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit, report two researchers who analyzed the patents on human DNA. Their study, published March 25 in the journal Genome Medicine, raises an alarm about the loss of individual "genomic liberty." In their new analysis, the research team examined two types of patented DNA sequences: long and short fragments. ...

Women make better decisions than men

2013-03-26

Hamilton, ON, March 25, 2013 – Women's abilities to make fair decisions when competing interests are at stake make them better corporate leaders, researchers have found. A survey of more than 600 board directors showed that women are more likely to consider the rights of others and to take a cooperative approach to decision-making. This approach translates into better performance for their companies. The study, which was published this week in the International Journal of Business Governance and Ethics, was conducted by Chris Bart, professor of strategic management ...

Gene therapy may aid failing hearts

2013-03-26

In an animal study, researchers at the University of Washington show that it was possible to use gene therapy to boost heart muscle function. The finding suggests that it might be possible to use this approach to treat patients whose hearts have been weakened by heart attacks and other heart conditions. Led by University of Washington (UW) Professor and Vice Chair of Bioengineering Michael Regnier and Dr. Chuck Murry, director of the Center for Cardiovascular Biology and co-director of the Institute for Stem Cell and Regenerative Medicine at UW, the study appears online ...

Auto accidents often occur on low-speed roads, but a high-speed trip encourages reluctant bucklers

2013-03-26

Since most driving is done locally, it is not surprising that most auto accidents occur during routine errands. Yet, occasional seatbelt users are more likely to buckle up for trips on high-speed roads and less likely to use the belts for local driving, according to an analysis of data from 100 instrumented vehicles reported in the January issue of Accident Analysis and Prevention. If drivers and front-seat passengers used seatbelts all the time, deaths from crashes would be reduced by 45 percent, according to the National Highway Traffic Safety Administration (NHTSA). ...

Compounds found that alter cell signaling, could lead to new breast cancer treatments

2013-03-26

JUPITER, FL, March 25, 2013 – Using a broad spectrum of analytical tools, scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a class of novel compounds that can alter cell signaling activity, resulting in a variety of responses including a strong anti-inflammatory effect. These findings could lead to new strategies for treating diseases such as breast cancer. The study, published this week in the journal Nature Chemical Biology, focuses on compounds that interact with the estrogen receptor-α, a therapeutic target in breast ...

The latest genomic studies of wheat sheds new light on crop adaptation and domestication

2013-03-26

March 25, 2013, Shenzhen, China – The advanced online publication version of Nature today presents two manuscripts that provide an unprecedented glimpse into the adaptation and domestication of wheat. These achievements are the results of joint efforts led by the Institute of Genetics and Developmental Biology (IGDB), Chinese Academy of Sciences, Chinese Academy of Agricultural Sciences (CAAS), and BGI. The two projects sequenced and analyzed two ancestral wheat genomes of Triticum urartu and Aegilops tauschii, respectively, throwing light on the biology of the world's ...

Ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance

2013-03-26

PHILADELPHIA — A drug that indirectly impairs the function of several cancer-driving proteins, including anaplastic lymphoma kinase (ALK), may be an effective new treatment for patients with ALK--positive non-small cell lung cancer. The drug, ganetespib, may also be effective for treating patients who have become resistant to the only FDA-approved targeted therapy for this disease, crizotinib, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research. "Lung cancer, a leading cause of death, is no longer thought of as ...

Early-onset baldness in African-American men may be linked to prostate cancer

2013-03-26

PHILADELPHIA — Baldness was associated with an increased risk of prostate cancer among African-American men, and risk for advanced prostate cancer increased with younger age and type of baldness, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "We focused on African-American men because they are at high risk for developing prostate cancer and are more than twice as likely to die from prostate cancer than other groups in the United States," said Charnita Zeigler-Johnson, Ph.D., research ...

Radiosurgery for treating unruptured intracranial arteriovenous malformations

2013-03-26

Charlottesville, VA (March 26, 2013). Researchers at the University of Virginia (UVA) Health System recommend radiosurgery for treating unruptured arteriovenous malformations (AVMs), because the procedure has a reasonable benefit-to-risk profile. They base this recommendation on an evaluation of clinical and radiographic outcomes in 444 patients treated with radiosurgery for unruptured AVMs at their institution. Detailed findings in this single-institution patient cohort are reported and discussed in "Radiosurgery for patients with unruptured intracranial arteriovenous ...

Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)

GMiS Celebrates Women's Accomplishments Through Open Nominations

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: